Document is current
Any future updates will be listed below
-
Authors
Lee, Won Hee https://orcid.org/0000-0002-0950-1851
Kim, Bun https://orcid.org/0000-0002-0039-7728
Nam, Chang Hyun
Yeo, Hyun Yang
Lee, Dong Woon
Park, Sung Chan
Oh, Jae Hwan
Han, Sung-Sik https://orcid.org/0000-0001-7047-7961
Lim, Myong Cheol
Kim, Hail https://orcid.org/0000-0002-6652-1349
Ju, Young Seok https://orcid.org/0000-0002-5514-4189
Chang, Hee Jin https://orcid.org/0000-0003-2263-2247
Cha, Yongjun https://orcid.org/0000-0001-5651-7939
-
Funding
Funding for this research was provided by:
Korea Health Industry Development Institute (RS-2024-00440005)
Korea Health Industry Development Institute (MD-PhD/Medical Scientist Training Program)
National Cancer Center (2211760)
National Cancer Center (2211760)
- License Information
-
More Information
Article History
Received: 28 November 2025
Accepted: 5 June 2026
First Online: 13 June 2026
Competing interests
: Y.S.J. is a co-founder and major shareholder of Inocras Inc., a San Diego-based precision medicine company. Y.C. is a consulting advisor for IMBdx, Inc, Seoul, Korea. The remaining authors declare no competing interests.
